OyaGen's Series C - II Round

OyaGen raised a round of funding on September 17, 2013. Investors include Trillium Group.

OyaGen is a biotechnology company discovering, developing, and commercializing pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. The company will pursue several assays…

Articles about OyaGen's Series C - II Round: